SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001999371-24-005736
Filing Date
2024-05-07
Accepted
2024-05-07 18:01:49
Documents
1
Group Members
AFFINITY HEALTHCARE FUND, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISTION OF BENEFICIAL OWNERSHIP eliem-sc13g_050724.htm SC 13G 42087
  Complete submission text file 0001999371-24-005736.txt   43754
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Subject) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92797 | Film No.: 24923521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017 917-826-4533
Affinity Asset Advisors, LLC (Filed by) CIK: 0001773195 (see all company filings)

IRS No.: 821567490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G